(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GRAIL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GRAIL

ST13

US500000086984014

Class

1, 5

Filing

86984014

Registration

5561536

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

62

Latest update

08/06/2026

Trademark type

Word

Nice classes

1, 5

Filing date

01/14/2016

Registration date

09/11/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/08/2025

Last transaction

08/06/2026

Responsible office

United States Patent and Trademark Office

Status code

704

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/08/2017

First use in commerce

02/08/2017

Drawing code

4

Owner type

03

Owner location

MENLO PARK, CA, US

Examiner

LEE, DOUGLAS

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

GRAIL, INC.
GRAIL, INC.
GRAIL, INC.

Representatives

Donald A Thompson THOMPSON & CO.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Assaysreagentsenzymesnucleotides for clinical or medical laboratoryscientificresearch purposes; diagnostic or screening assaysreagentsenzymesnucleotides for clinical or medical laboratoryscientificresearch purposes; reagents for medical and genetic research use; chemical reagents and diagnostic preparations for clinical or medical laboratory use

Class 5

Medical diagnostic reagents and medical diagnostic kits comprised of medical diagnostic reagents; reagents for medical use and medical diagnostics or screening kits comprised of reagents for medical diagnostics or screening use ; reagents for use in genetic testing for medical and medical diagnostic purposes; diagnostic preparations for medical purposes; assaysreagentsenzymesnucleotides for medical or clinical diagnostics or screening purposes; diagnostic assaysreagentsenzymesnucleotides for medical or clinical purposes

Publications

History of USPTO decisions and trademark events.

62 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

06/08/2025

8.PR

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED

06/08/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/08/2025

ES8R

TEAS SECTION 8 RECEIVED

02/21/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/29/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/11/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/18/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/18/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/18/2022

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

02/18/2022

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

02/18/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/27/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/27/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/27/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

09/11/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/07/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/06/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/25/2018

DPCC

DIVISIONAL PROCESSING COMPLETE

07/25/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/24/2018

IUAF

USE AMENDMENT FILED

07/09/2018

DRRR

DIVISIONAL REQUEST RECEIVED

07/09/2018

EISU

TEAS STATEMENT OF USE RECEIVED

07/09/2018

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

07/09/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/09/2018

EX3G

SOU EXTENSION 3 GRANTED

05/07/2018

EXT3

SOU EXTENSION 3 FILED

05/07/2018

EEXT

SOU TEAS EXTENSION RECEIVED

05/07/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/03/2017

EX2G

SOU EXTENSION 2 GRANTED

11/01/2017

EXT2

SOU EXTENSION 2 FILED

11/01/2017

EEXT

SOU TEAS EXTENSION RECEIVED

11/01/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/17/2017

EX1G

SOU EXTENSION 1 GRANTED

05/15/2017

EXT1

SOU EXTENSION 1 FILED

05/15/2017

EEXT

SOU TEAS EXTENSION RECEIVED

05/15/2017

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/13/2017

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/13/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/22/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/27/2016

PUBO

PUBLISHED FOR OPPOSITION

09/27/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/07/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/19/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/16/2016

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/13/2016

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/13/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/08/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/08/2016

ALIE

ASSIGNED TO LIE

07/05/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/29/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/24/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/24/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/20/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/20/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/06/2016

GNRT

NON-FINAL ACTION E-MAILED

05/06/2016

CNRT

NON-FINAL ACTION WRITTEN

05/06/2016

DOCK

ASSIGNED TO EXAMINER

04/29/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/21/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/21/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/20/2016

NWAP

NEW APPLICATION ENTERED

01/18/2016

Continuous trademark protection

Get notified about every new filing that threatens GRAIL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.